Title: Transcatheter Closure of Patent Ductus Arteriosus- Observational Data Comparing Device and Coil

Authors: N.Jayaprasad DM, Suresh Madhavan DM

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i1.08

Abstract

Background: Transcatheter closure of PDA has largely replaced surgical ligation in different age groups. Coils and Amplatzer Duct Occluder (ADO) are the most frequently used closure devices.

Aim: Aim of the study is to compare our data on the outcome and complications of transcatheter coil closure of PDA with that of device closure.

Methods: From April 2014 to April 2017, 57 patients underwent transcatheter closure of PDA in our centre and were included in the study. Echocardiographic, angiographic data and procedure results were analysed.

Results: During the study period 24 patients underwent PDA coil closure and 33 patients underwent device closure. Coils were used mostly in small and moderate sized PDA whereas ADO was used in moderate to large PDA. Procedure success was 96.9% for device and 91.6% for coil closure. In the immediate post-procedure period residual shunts tended to be more in coil closure group. Complications were rare in both groups.

Conclusions: Transcatheter closure of PDA is very safe and effective and achieves near complete occlusion in most cases. Coil closure is nearly as effective as device closure in small and moderate sized PDA.

References

  1. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation 1971;43:323—32.
  2. Rao PS. Transcatheter occlusion of patent ductus arteriosus: which method to use and which ductus to close. Am Heart J 1996; 132: 905-909.
  3. Cambier PA, Kirby WC, Wortham DC, Moore JW. Percutaneous closure of the small patent ductus arteriosus using coil embolization. Am J Cardiol 1992; 69: 815-816.
  4. Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amp-latzer patent ductusarteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 2004; 44: 513-519.
  5. Roberts P, Adwani S, Archer N, Wilson N. Catheter closure of the arterialduct in preterm infants. Arch Dis Child Fetal Neonatal 2007 Ed 92: F248-250.
  6. Francis E, Singhi AK, Lakshmi venkateshaiah S, Kumar RK. Transcatheter occlusion of patent ductus arteriosus in pre-term infants. JACC Cardiovasc Interv.2010; 3: 550-555.
  7. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guide-lines for the management of grown-up congenital heart disease(new version 2010). Eur Heart J 2010;31:2915—57.
  8. Rao PS. Summary and Comparison of Patent Ductus Arteriosus Closure Devices. CurrInterv Cardiol Rep 2001; 3: 268-274.
  9. Tomita H, Fuse S, Akagi T, Matsumoto Y, Murakami Y, et al. Hemolysis compli-cating coil occlusion of patent ductus arteriosus. Cathet Cardiovasc Diagn 1998; 43: 50-53.
  10. Gupta K, Rao PS. Severe intravascular hemolysis after transcatheter coil occlusion of patent ductus arteriosus. J Invasive Cardiol 2005; 17: E15-17.
  11. Rao PS. Percutaneous closure of patent ductusarteriosus—current status. J Invasive Cardiol 2011; 23: 517-520.
  12. Amanullah MM, Siddiqui MT, Khan MZ, et al. Surgical rescue of embolized Ampl-atzer devices. J Card Surg 2011;26:254—8.
  13. Pfammatter JP, Meier B. Successful repositioning of an Amplatzer duct occluder immediately after inadvertent embolization in the descending aorta. Catheter Cardiovasc Interv 2003;59:83—5.
  14. Duke C, Chan KC. Aortic obstruction caused by device occlusion of patent arterial duct. Heart 1999;82: 109-111.
  15. Fischer G, Stieh J, Uebing A, Grabitz R, Kramer HH. Transcatheter closure of persistent ductus arteriosus in infants using the Amplatzer duct occluder. Heart 2001;86: 444-447.

Corresponding Author

N. Jayaprasad

Associate Professor, Dept of Cardiology,

Government Medical College, Kottayam -686008, Kerala, India

Phone number: 91 9446723547, Email: This email address is being protected from spambots. You need JavaScript enabled to view it.